Latest Market Engagement News

Magnum Mining & Exploration is recalibrating its supply chain strategy in response to new U.S. tariffs on steel and aluminium, engaging with Chinese partners and advancing its Buena Vista iron project.

Solis Minerals appoints Mitch Thomas as CEO, shifting Mike Parker to Technical Director, ahead of a major 2025 drilling campaign in Peru's copper-rich belt.

NH3 Clean Energy has signed a non-binding Memorandum of Understanding with Pilbara Ports Authority to explore exporting 600,000 tonnes per annum of clean ammonia from its WAH2 Project, marking a key step in Australia's clean energy export ambitions.

Westar Resources has secured heritage approvals and is set to begin a targeted RC drilling program at the Mindoolah Gold Mining Centre, aiming to unlock high-grade gold deposits beneath historic workings. Following this, drilling will focus on a compelling geophysical anomaly at the Mageye Prospect.

Alpha HPA Limited has announced key leadership changes, appointing Rob Williamson as Managing Director and repositioning Rimas Kairaitis as Executive Director and Chief Commercial Officer to support its next growth phase.

Spenda Limited has reported a record-breaking quarter with cash receipts soaring 160% year-on-year and payment volumes more than doubling, signaling strong momentum as it advances toward profitability.

Cadoux Limited reports significant progress in its high purity alumina and Minhub rare earths projects, alongside robust environmental, social, and governance initiatives.

Pure Resources Limited has made significant strides in its Reedy Creek Garnet Project, expanding the resource and delivering promising metallurgical test results that highlight the project's commercial potential.

Aspire Mining Limited has made significant strides in developing its Ovoot Coking Coal Project, progressing construction tenders and customer engagement despite a challenging coal market.

Arovella Therapeutics has bolstered its financial position with a $20 million placement, fully funding the Phase 1 clinical trial of its lead CAR-iNKT therapy, ALA-101, targeting CD19-positive blood cancers. The company also established a Clinical Advisory Board and anticipates key regulatory and clinical milestones in 2025.

Jatcorp Limited faces a sharp revenue drop due to a trademark dispute in China but accelerates growth with new Moroka® products and expanded distribution channels.

GreenHy2 Limited reports a slight cash decline but strengthens its foothold in renewable energy with key partnerships and strategic pivots in hydrogen storage technology.